Health News

Genetic Two for Two
For years, scientists have tried to identify the genes involved in the development of oligodendrogliomas - the second most common form of brain cancer. They've finally done it.
Glue Ear Infections Healed with Disolving Pellets
When thick, sticky fluid collects behind the ear drum over a period of weeks and months, patients can develop glue ear, a painless condition that could lead to hearing loss. Scientists have found an innovative way to treat it.
Doubling Progression-Free Survival
Being diagnosed with lung cancer usually means months of chemotherapy followed by a relapse. That outlook is changing for the better.
Seeing Sudden Death on Dialysis
When a diabetes patient's kidneys fail, that patient has to be put on dialysis. These patients may be at risk of having their heart suddenly stop. Now, researchers have found a way to spot who is most at risk.
Planet Health Helps Prevent Eating Disorders
Prevention methods for the obesity epidemic are well underway. But, sometimes these techniques can be too forward and have negative side effects like children developing eating disorders.
A New Right Next Step
When a man has an elevated PSA (prostate specific antigen) level, the next step is often a biopsy to see if it's cancer. That step may soon be supplemented or replaced with a urine test.
Starving Cancer to Death
Like every other living organism, cancer cells need food to live. They live off glucose to grow and spread. Scientists have identified two compounds that block the sugar and starves the cancer.
Staying Alive and Fighting Back
Rape, sexual assault, and violence can happen to anyone, especially women. The aftermath of being attacked can be detrimental to the victim's health - more specifically mental health.
Four Loko At It Again
Caffeinated alcoholic drinks have created quite the stir and definitely not the good kind. Teens are now ending up in the emergency room from drinking too many of these types of drinks.
Medtronic Hires Yale to Review Spine Product
Criticism has prompted Medtronic to offer Yale University $2.5 million for two independent studies of its controversial Infuse spinal fusion product.